ALX 5407: A potent, selective inhibitor of the hGlyT1 glycine transporter

Molecular Pharmacology

Volumn 60, Issue 6, 2001, Pages 1414-1420

  Atkinson, B N ^a   Bell, S C ^a   De Vivo, M ^a   Kowalski, L R ^a   Lechner, S M ^a   Ognyanov, V I ^a   Tham, C S ^a   Tsai, C ^a   Jia, J ^a   Ashton, D ^a   Klitenick, M A ^a  

^a DesignWrite   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALX 5407; CARRIER PROTEIN; CHLORIDE ION; GLYCINE TRANSPORTER; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SARCOSINE; SODIUM ION; UNCLASSIFIED DRUG; [N [3 (4' FLUOROPHENYL) 3 (4' PHENYLPHENOXY)PROPYL]]SARCOSINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG SELECTIVITY; FIBROBLAST; IC 50; MICHAELIS MENTEN KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0035206917     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.60.6.1414     Document Type: Article

References (30)

1. Intracerebroventricular infusion of the NMDA receptor-associated glycine site antagonist 7-chlorokynurenate impairs water maze performance but fails to block hippocampal long-term potentiation in vivo
2. Long-term potentiation of NMDA receptor-mediated synaptic transmission in the hippocampus
3. Modulation of N-methyl-D-aspartate receptor function by glycine transport
4. Two glycine transporter variants with distinct localization in the CNS and peripheral tissues are encoded by a common gene
5. Interaction between glutamatergic and monoaminergic systems within the basal ganglia: Implications for schizophrenia and Parkinson's disease
6. Modulation of excitatory synaptic transmission by glycine and zinc in cultures of mouse hippocampal neurons
7. Glycinergic augmentation of NMDA receptor-mediated neurotransmission in the treatment of schizophrenia
8. Glycyldodecylamide, a phencyclidine behavioral antagonist, blocks cortical glycine uptake: Implications for schizophrenia and substance abuse
9. Recent advance in the phencyclidine model of schizophrenia
10. Glycine potentiates the NMDA response in cultured mouse brain neurons
11. The glycine site of the NMDA receptor-five years on
12. Cloning of the human glycine transporter type 1: Molecular and pharmacological characterization of novel isoform variants and chromosomal localization of the gene in the human and mouse genomes
13. Requirement for glycine in activation of NMDA receptors expressed in Xenopus oocytes
14. Study of a new schizophrenomimetic drug
15. NMDA receptor function and human cognition: The effects of ketamine in healthy volunteers
16. Regulation of NMDA receptor desensitization in mouse hippocampal neurons by glycine
17. Glutamate receptors: Brain function and signal transduction
18. Glycine binding sites reciprocally interact with glutamate binding sites at NMDA receptor complex
19. Glutamate receptor dysfunction and schizophrenia
20. NMDA receptor hypofunction model of schizophrenia
21. Deficient NMDA-mediated glutamate release from synaptosomes of schizophrenics
22. Schizophrenia and glutamatergic transmission
23. Limbic system: Localization of PCP drug action in rat and schizophrenic manifestations in humans
24. Glycine enhances NMDA-receptor mediated synaptic potentials in neocortical slices
25. Functional antagonists at the NMDA receptor complex exhibit antidepressant action
26. Effects of glycine and structurally related amino acids on generation of long-term potentiation in rat hippocampal slices
27. Glycine therapy of schizophrenia
28. Regional distribution and developmental variation of the glycine transporters GlyT1 and GlyT2 in the rat CNS